[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339946-105":59,"doc-detail-339946-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","patient-experience-of-hepatocellular-carcinoma-and-their-treatment-goals-an-international-qualitative-study-and-patient-journey-map","Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals - An International Qualitative Study and Patient Journey Map","","Understanding the patient journey of hepatocellular carcinoma (HCC) can support future clinical decision-making and improve patient experience. This international qualitative study explored how patients experience HCC in relation to treatment options, decision-making, and goals across early, intermediate, and advanced stages. It also identified key symptoms and impacts. Semi-structured interviews were analyzed using directed content analysis, revealing HCP-led decisions and goals focused on overall survival and quality of life.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/patient-experience-of-hepatocellular-carcinoma-and-their-treatment-goals-an-international-qualitative-study-and-patient-journey-map/339946/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/patient-experience-of-hepatocellular-carcinoma-and-their-treatment-goals-an-international-qualitative-study-and-patient-journey-map/339946.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this international qualitative study on HCC?","Question",{"text":112,"@type":113},"The study aimed to explore the patient journey of hepatocellular carcinoma in relation to treatment options, treatment decision-making, and treatment goals, and to assess symptoms and impacts across disease stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were data collected and analyzed in the study?",{"text":117,"@type":113},"Semi-structured 60-minute interviews were conducted with 50 patients with HCC and 12 healthcare professionals. Interview data were analyzed using directed content analysis with a hybrid inductive and deductive approach, including assessment of conceptual saturation.",{"name":119,"@type":110,"acceptedAnswer":120},"What treatment goals did patients and healthcare professionals prioritize?",{"text":121,"@type":113},"Patients emphasized extending overall survival and preserving quality of life, with those having advanced/unresectable HCC prioritizing quality of life. Healthcare professionals also prioritized overall survival and progression-free survival, noting quality of life became more important as HCC progressed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339946,1791283740,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Adv Ther (2024) 41:3598–3614  \n[https://doi.org/10.1007/s12325-024-02939-1](https://doi.org/10.1007/s12325-024-02939-1)  \nORIGINAL RESEARCH  \nPatient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map  \nMarcus‑Alexander Wörns · Danielle Burns · Michael Paskow · Harriet Makin · Jordan Miller · Lucy M. Turner · Janvi Sah  \nReceived: March 14, 2024 / Accepted: June 26, 2024 / Published online: July 25, 2024 © The Author(s) 2024  \nABSTRACT  \nIntroduction: Understanding the patient journey of hepatocellular carcinoma (HCC) may inform future clinical decision‑making and enhance the patient experience. The objec‑ tives of this study were to explore the patient  \n\n| Prior Presentation: The results presented in this manuscript were previously presented at the European Society for Medical Oncology (ESMO) conference in Madrid, Spain, held from October 20 to 24, 2023. |\n| --- |\n| Supplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12325](https://doi.org/10.1007/s12325)‑024‑02939‑1. |\n\nM.‑A. Wörns  \nDepartment of Gastroenterology, Hematology, Medical Oncology and Endocrinology, Klinikum Dortmund, Klinikum of the University Witten/ Herdecke, Dortmund, Germany  \nD. Burns · H. Makin · J. Miller  \nClinical Outcomes Assessment, Clarivate Analytics, London, UK  \nM. Paskow  \nGlobal Medical Affairs, AstraZeneca, Gaithersburg, MD, USA  \nL. M. Turner  \nGlobal Medical Affairs, AstraZeneca, Cambridge, UK J. Sah (*)  \nOncology Outcomes Research, AstraZeneca, Gaithersburg, MD, USA  \ne‑mail: [janvi.sah@astrazeneca.com](janvi.sah@astrazeneca.com)  \nexperience of HCC in relation to treatment options, treatment decision‑making and treat‑ ment goals throughout the disease journey. This study also aimed to determine the symptoms and impacts of HCC across early, intermediate and advanced HCC.  \nMethods: Semi‑structured 60‑min interviews were conducted with n = 50 patients with HCCand n = 12 healthcare professionals (HCPs) with experience of treating patients with HCC. Inter‑ view data were analyzed using directed content analysis techniques with a hybrid inductive and deductive approach. An assessment of con‑ ceptual saturation was conducted for patients’symptom experience.  \nResults: Patients described treatment deci‑ sions as mostly HCP‑led. In this study, sur‑ gery/resection was the most frequently offered treatment option across the HCC journey, and most patients were satisfied with the treatment options presented to them. Overall, patients described extending their overall survival (OS) and preserving quality of life (QoL) as their most important treatment goals, with patients diagnosed with advanced/unresectable HCC prioritizing QoL. HCPs also prioritized OS and progression‑free survival (PFS) though reported that QoL became more important as HCC pro‑ gressed. Patients experienced various symptoms  \nacross the HCC journey including fatigue, nau‑ sea, appetite loss, diarrhea and pain. Conclusion: Overall, HCPs and patients col‑ laborate throughout the treatment journey regarding treatment decisions and shared treat‑ ment goals. OS is critically important to patients and HCPs, though treatment goals may change depending on various clinical factors.  \nPLAIN LANGUAGE SUMMARY  \nLiver cancer is the third leading cause of cancer death worldwide. Very few studies have directly explored how patients experience liver cancer and its treatment. This research was performed to understand the patient experience of liver cancer including treatment decisions and goals, communication dynamics between patients and their treating doctors, the types of treatment offered to patients and symptoms that patients experience while living with liver cancer. Patients and doctors were interviewed to under‑ stand their experience of living with and treat‑ ing liver cancer. Overall, patients and doctors work together to decide on treatment. Patients ","cbCaihUG4yzouzFv","https://ap.wps.com/l/cbCaihUG4yzouzFv","pdf",653350,17,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion\n# Plain Language Summary\n# Key Summary Points\n## Why carry out this study?\n## What was learned from this study?","[{\"question\":\"What was the purpose of this international qualitative study on HCC?\",\"answer\":\"The study aimed to explore the patient journey of hepatocellular carcinoma in relation to treatment options, treatment decision-making, and treatment goals, and to assess symptoms and impacts across disease stages.\"},{\"question\":\"How were data collected and analyzed in the study?\",\"answer\":\"Semi-structured 60-minute interviews were conducted with 50 patients with HCC and 12 healthcare professionals. Interview data were analyzed using directed content analysis with a hybrid inductive and deductive approach, including assessment of conceptual saturation.\"},{\"question\":\"What treatment goals did patients and healthcare professionals prioritize?\",\"answer\":\"Patients emphasized extending overall survival and preserving quality of life, with those having advanced/unresectable HCC prioritizing quality of life. Healthcare professionals also prioritized overall survival and progression-free survival, noting quality of life became more important as HCC progressed.\"}]","Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals - An International Qualitative Study and Patient Journey Map | PDF",1790033257,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd013508609eb3353b570a8190b8a9e3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a11e77d78209dabcc7440e86e21c435e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d23ee16f9e691dc8d7e570d59666ffd2.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c9e4b257b8ef4fd48475370a376fc9d.webp",980,1301]